دورية أكاديمية
أعرض في EDS

Clinical characteristics, diagnosis, and treatment of central nervous system sporotrichosis: Systematic review and meta-analysis.

التفاصيل البيبلوغرافية
العنوان: Clinical characteristics, diagnosis, and treatment of central nervous system sporotrichosis: Systematic review and meta-analysis.
المؤلفون: de Oliveira VF; Department of Infectious and Parasitic Diseases, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Petrucci JF; Department of Infectious and Parasitic Diseases, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Taborda M; Department of Infectious and Parasitic Diseases, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Brener PZ; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Kremer PGBB; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Randi BA; Department of Infectious and Parasitic Diseases, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Magri ASGK; Department of Infectious and Parasitic Diseases, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Magri MMC; Department of Infectious and Parasitic Diseases, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Levin AS; Department of Infectious and Parasitic Diseases, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Silva GD; Department of Neurology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
المصدر: Mycoses [Mycoses] 2024 Feb; Vol. 67 (2), pp. e13697.
نوع المنشور: Meta-Analysis; Systematic Review; Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Grosse Verlag Country of Publication: Germany NLM ID: 8805008 Publication Model: Print Cited Medium: Internet ISSN: 1439-0507 (Electronic) Linking ISSN: 09337407 NLM ISO Abbreviation: Mycoses
أسماء مطبوعة: Original Publication: Berlin : Grosse Verlag, [1988?-
مواضيع طبية MeSH: Sporotrichosis*/drug therapy , Sporotrichosis*/diagnosis , Sporothrix*/isolation & purification , Antifungal Agents*/therapeutic use, Humans ; Cats ; Male ; Adult ; Female ; Animals ; Brazil/epidemiology ; Central Nervous System Fungal Infections/drug therapy ; Central Nervous System Fungal Infections/microbiology ; Central Nervous System Fungal Infections/diagnosis ; Central Nervous System Fungal Infections/mortality ; United States/epidemiology
مستخلص: Background: The clinical features of central nervous system (CNS) sporotrichosis are derived from case reports and a limited series of cases. Our objective was to carry out a systematic review and meta-analysis of CNS sporotrichosis.
Methods: We searched PubMed/MEDLINE, Embase, Scopus, and LILACS on 9 September 2023. Our inclusion criteria were documentation of Sporothrix and demonstrated CNS involvement. A metaproportion or metamean analysis was performed to estimate a summary proportion with 95% confidence intervals.
Results: We included 52 cases of CNS sporotrichosis published from 1966 to 2023. Forty-six patients were male (88%, 95% CI: 77-95), and the mean age was 39 years (95% CI: 36-43). Close contact with cats was reported in 55% of cases (95% CI: 37-72). Thirty-two (61.5%) patients were from Brazil, 18 patients from the United State of America (34.6%). Only two Sporothrix species were reported: S. schenckii (26/41, 63%), and S. brasiliensis (15/41, 37%). The most common neurological symptom was headache. Meningitis was chronic in approximately 80% of cases. A significant majority of the patients were immunocompromised. HIV infection was the primary cause of immunosuppression (85%, 95% CI: 61-95). Overall mortality was 56% (22/39). The comparison of Kaplan-Meier survival curve showed a higher mortality with a statistically significant difference in immunosuppressed patients (p = .019).
Conclusion: CNS sporotrichosis represents a notable cause of chronic meningitis, especially in individuals living in the Americas with HIV infection and concurrent skin lesions.
(© 2024 Wiley-VCH GmbH. Published by John Wiley & Sons Ltd.)
References: Thompson GR, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021;21(12):e364-e374. doi:10.1016/S1473-3099(21)00191-2.
Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2015;53(1):3-14. doi:10.1093/mmy/myu062.
Rodrigues AM, Della Terra PP, Gremião ID, Pereira SA, Orofino-Costa R, de Camargo ZP. The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia. 2020;185(5):813-842. doi:10.1007/s11046-020-00425-0.
Bonifaz A, Tirado-Sánchez A. Cutaneous disseminated and extracutaneous sporotrichosis: current status of a complex disease. J Fungi (Basel). 2017;3(1):6. doi:10.3390/jof3010006.
Orofino-Costa R, de Macedo PM, Rodrigues AM, Bernardes-Engemann AR. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017;92(5):606-620. doi:10.1590/abd1806-4841.2017279.
Oliveira MME, Muniz M d M, Almeida-Paes R, et al. Cerebrospinal fluid PCR: a new approach for the diagnosis of CNS sporotrichosis. PLoS Negl Trop Dis. 2020;14(7):e0008196. doi:10.1371/journal.pntd.0008196.
Lima MA, Freitas DFS, Oliveira RVC, et al. Meningeal sporotrichosis due to Sporothrix brasiliensis: a 21-year cohort study from a Brazilian reference center. J Fungi (Basel). 2022;9(1):17. doi:10.3390/jof9010017.
Freitas DFS, Lima MA, de Almeida-Paes R, et al. Sporotrichosis in the central nervous system caused by Sporothrix brasiliensis. Clin Infect Dis. 2015;61(4):663-664. doi:10.1093/cid/civ361.
Page M, McKenzie J, Bossuyt P, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
Wescott BL, Nasser A, Jarolim DR. Sporothrix meningitis. Nurse Pract. 1999;24(2):90-98.
Hessler C, Kauffman CA, Chow FC. The upside of bias: a case of chronic meningitis due to sporothrix schenckii in an immunocompetent host. Neurohospitalist. 2017;7(1):30-34. doi:10.1177/1941874416641468.
Paixão AG, Galhardo MCG, Almeida-Paes R, et al. The difficult management of disseminated Sporothrix brasiliensis in a patient with advanced AIDS. AIDS Res Ther. 2015;12:16. doi:10.1186/s12981-015-0051-1.
Perrault JL, Endelman LA, Kraemer MR, Chen D, Lake WB, Salamat MS. Intramedullary disseminated sporotrichosis in an immunocompetent patient: case report and review of the literature. BMC Infect Dis. 2023;23(1):450. doi:10.1186/s12879-023-08344-3.
Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis. 1987;9(2):369-375. doi:10.1093/clinids/9.2.369.
Galhardo MCG, Silva MTT, Lima MA, et al. Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome. J Neurol Neurosurg Psychiatry. 2010;81(6):696-699. doi:10.1136/jnnp.2009.173187.
Arantes Ferreira GS, Watanabe ALC, Trevizoli NC, et al. Disseminated sporotrichosis in a liver transplant patient: a case report. Transplant Proc. 2019;51(5):1621-1624. doi:10.1016/j.transproceed.2019.02.019.
Mialski R, de Almeida JN, da Silva LH, et al. Chronic meningitis and hydrocephalus due to Sporothrix brasiliensis in immunocompetent adults: a challenging entity. Open Forum Infect Dis. 2018;5(5):ofy081. doi:10.1093/ofid/ofy081.
Vilela R, Souza GF, Fernandes Cota G, Mendoza L. Cutaneous and meningeal sporotrichosis in a HIV patient. Rev Iberoam Micol. 2007;24(2):161-163. doi:10.1016/s1130-1406(07)70035-9.
Duani H, Palmerston MF, Rosa Júnior JF, Ribeiro VT, Alcântara Neves PL. Meningeal and multiorgan disseminated sporotrichosis: a case report and autopsy study. Med Mycol Case Rep. 2019;26:47-52. doi:10.1016/j.mmcr.2019.10.005.
Silva-Vergara ML, Maneira FRZ, De Oliveira RM, Santos CTB, Etchebehere RM, Adad SJ. Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol. 2005;43(2):187-190. doi:10.1080/13693780500035904.
Lima MA, Vallier R, Silva MM. Sporothrix brasiliensis meningitis in an immunocompetent patient. Pract Neurol. 2021;21(3):241-242. doi:10.1136/practneurol-2020-002915.
Penn CC, Goldstein E, Bartholomew WR. Sporothrix schenckii meningitis in a patient with AIDS. Clin Infect Dis. 1992;15(4):741-743. doi:10.1093/clind/15.4.741.
Donabedian H, O'Donnell E, Olszewski C, MacArthur RD, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis. 1994;18(2):111-115. doi:10.1016/0732-8893(94)90075-2.
Ewing GE, Bosl GJ, Peterson PK. Sporothrix schenckii meningitis in a farmer with Hodgkin's disease. Am J Med. 1980;68(3):455-457. doi:10.1016/0002-9343(80)90120-5.
Scott EN, Kaufman L, Brown AC, Muchmore HG. Serologic studies in the diagnosis and management of meningitis due to Sporothrix schenckii. N Engl J Med. 1987;317(15):935-940. doi:10.1056/NEJM198710083171505.
Satterwhite TK. Disseminated sporotrichosis. JAMA. 1978;240(8):771. doi:10.1001/jama.1978.03290080061031.
Klein RC. Meningitis due to Sporotrichum schenckii. Arch Intern Med. 1966;118(2):145. doi:10.1001/archinte.1966.00290140049010.
Freeman JW, Ziegler DK. Chronic meningitis caused by Sporotrichum schenckii. Neurology. 1977;27(10):989-992. doi:10.1212/wnl.27.10.989.
Zetina LA, Dávila CP, Hernández E, José Luis BC. Reporte del primer caso en el mundo de paquimeningitis hipertrófica espinal secundaria a Sporothrix schenkii. Rev Med Interna. 1999;10(2):36-37.
Cite Rotz LD, Slater LN, Wack MF, Boyd AL, Scott EN, Greenfield RA. Disseminated sporotrichosis with meningitis in a patient with AIDS. Infectious Diseases in Clinical Practice. 1996;5(9):566-568.
Gutiérrez Morales JL, Domínguez RM, Morales ME, Rossiere NLE, Reyes BG, Alejandro SR. Esporotricosis micetomatoide con invasión a médula espinal. Revista Mexicana de Neurociencia. 2011;12(1):50-54.
Hernández-Castro R, Pinto-Almazán R, Arenas R, et al. Epidemiology of clinical sporotrichosis in the americas in the last ten years. J Fungi (Basel). 2022;8(6):588. doi:10.3390/jof8060588.
Fichman V, Freitas DFS, do Valle ACF, et al. Severe sporotrichosis treated with amphotericin B: a 20-year cohort study in an endemic area of zoonotic transmission. J Fungi (Basel). 2022;8(5):469. doi:10.3390/jof8050469.
Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol. 1999;37(6):397-404. doi:10.1046/j.1365-280x.1999.00239.x.
Freitas DFS, de Siqueira Hoagland B, do Valle ACF, et al. Sporotrichosis in HIV-infected patients: report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil. Med Mycol. 2012;50(2):170-178. doi:10.3109/13693786.2011.596288.
Almeida-Silva F, Almeida MA, Rabello VBS, et al. Evaluation of five non-culture-based methods for the diagnosis of meningeal sporotrichosis. J Fungi (Basel). 2023;9(5):535. doi:10.3390/jof9050535.
de Oliveira LC, Almeida-Paes R, Pizzini CV, Gutierrez-Galhardo MC, Freitas DFS, Zancopé-Oliveira RM. Diagnostic performance of mycologic and serologic methods in a cohort of patients with suspected sporotrichosis. Rev Iberoam Micol. 2019;36(2):61-65. doi:10.1016/j.riam.2018.09.002.
Silva GD, Guedes BF, Junqueira IR, Gomes HR, Vidal JE. Diagnostic and therapeutic approach to chronic meningitis in Brazil: a narrative review. Arq Neuropsiquiatr. 2022;80(11):1167-1177. doi:10.1055/s-0042-1758645.
Schechtman RC, Falcão EMM, Carard M, García MSC, Mercado DS, Hay RJ. Sporotrichosis: hyperendemic by zoonotic transmission, with atypical presentations, hypersensitivity reactions and greater severity. An Bras Dermatol. 2022;97(1):1-13. doi:10.1016/j.abd.2021.07.003.
de Oliveira VF, Magri MMC, Levin AS, Silva GD. Systematic review of neuroparacoccidioidomycosis: the contribution of neuroimaging. Mycoses. 2023;66(2):168-175. doi:10.1111/myc.13525.
de Oliveira VF, Kruschewsky WLL, Sekiguchi WK, et al. Clinical, radiological and laboratory characteristics of central nervous system histoplasmosis: a systematic review of a severe disease. Mycoses. 2023;66(8):659-670. doi:10.1111/myc.13600.
Freitas DFS, do Valle ACF, da Silva MBT, et al. Sporotrichosis: an emerging neglected opportunistic infection in HIV-infected patients in Rio de Janeiro, Brazil. PLoS Negl Trop Dis. 2014;8(8):e3110. doi:10.1371/journal.pntd.0003110.
Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(10):1255-1265. doi:10.1086/522765.
Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. For the mycoses study group. Infectious Diseases Society of America. Clin Infect Dis. 2000;30(4):684-687. doi:10.1086/313751.
Kauffman CA. Central nervous system infection with other endemic mycoses: rare manifestation of blastomycosis, Paracoccidioidomycosis, Talaromycosis, and sporotrichosis. J Fungi (Basel). 2019;5(3):64. doi:10.3390/jof5030064.
Wirth F, Ishida K. Antifungal drugs: an updated review of central nervous system pharmacokinetics. Mycoses. 2020;63(10):1047-1059. doi:10.1111/myc.13157.
Ministério da Saúde. Guia de Vigilância em Saúde. 2022. Ministério da Saúde. Accessed January 3, 2024. https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_5ed_rev_atual.pdf.
فهرسة مساهمة: Keywords: Sporothrix; central nervous system; meningitis; sporotrichosis
المشرفين على المادة: 0 (Antifungal Agents)
SCR Organism: Sporothrix schenckii; Sporothrix brasiliensis
تواريخ الأحداث: Date Created: 20240220 Date Completed: 20240807 Latest Revision: 20240807
رمز التحديث: 20240808
DOI: 10.1111/myc.13697
PMID: 38374494
قاعدة البيانات: MEDLINE
الوصف
تدمد:1439-0507
DOI:10.1111/myc.13697